Benzothiazole Amides as TRPC3/6 Inhibitors for Gastric Cancer Treatment

[Image: see text] Transient receptor potential canonical channel 6 (TRPC6) has been implicated in many kinds of malignant tumors, but very few potent TRPC6 antagonists are available. In this study, a benzothiazole amide derivative 1a was discovered as a TRPC6 activator in a cell-based high-throughpu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ACS Omega
Autors principals: Wei, Yingjie, Zhang, Mengxian, Lyu, Zhenbin, Yang, Guolin, Tian, Tian, Ding, Mingmin, Zeng, Xiaodong, Xu, Fuchun, Wang, Pengyu, Li, Fangfang, Liu, Yixuan, Cao, Zhengyu, Lu, Jing, Hong, Xuechuan, Wang, Hongbo
Format: Artigo
Idioma:Inglês
Publicat: American Chemical Society 2021
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8028158/
https://ncbi.nlm.nih.gov/pubmed/33842788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.1c00514
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars